177 related articles for article (PubMed ID: 9813621)
41. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
42. Idiopathic urinary stone disease: possible polygenic aetiological factors.
Watts RW
QJM; 2005 Apr; 98(4):241-6. PubMed ID: 15781479
[No Abstract] [Full Text] [Related]
43. Is nephrocalcin related to the urinary derivative (bikunin) of inter-alpha-trypsin inhibitor?
Tang Y; Grover PK; Moritz RL; Simpson RJ; Ryall RL
Br J Urol; 1995 Oct; 76(4):425-30. PubMed ID: 7551874
[TBL] [Abstract][Full Text] [Related]
44. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
Gohel MD; Shum DK; Tam PC
Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
[TBL] [Abstract][Full Text] [Related]
45. Inter-alpha-trypsin inhibitor and its related proteins in Syrian hamster urine and plasma.
Yamamoto T; Yamamoto K; Sinohara H
J Biochem; 1996 Jul; 120(1):145-52. PubMed ID: 8864857
[TBL] [Abstract][Full Text] [Related]
46. Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone.
Umekawa T; Kurita T
Biochem Mol Biol Int; 1994 Sep; 34(2):309-13. PubMed ID: 7849642
[TBL] [Abstract][Full Text] [Related]
47. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
Sallis JD; Lumley MF
Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
[TBL] [Abstract][Full Text] [Related]
48. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
Priyadarshini ; Singh SK; Tandon C
Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
[TBL] [Abstract][Full Text] [Related]
49. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
[TBL] [Abstract][Full Text] [Related]
50. Expression of a functional proteinase inhibitor capable of accepting xylose: bikunin.
Falkenberg C; Wester L; Belting M; Eklund E; Akerström B
Arch Biochem Biophys; 2001 Mar; 387(1):99-106. PubMed ID: 11368189
[TBL] [Abstract][Full Text] [Related]
51. Inter-alpha-inhibitor, hyaluronan and inflammation.
Fries E; Kaczmarczyk A
Acta Biochim Pol; 2003; 50(3):735-42. PubMed ID: 14515153
[TBL] [Abstract][Full Text] [Related]
52. Exclusion mapping of major crystallization inhibitors in idiopathic calcium urolithiasis.
Cailhier JF; Petrucci M; Valiquette L; Guay G; Ouimet D; Bonnardeaux A
J Urol; 2001 Oct; 166(4):1484-6. PubMed ID: 11547117
[TBL] [Abstract][Full Text] [Related]
53. Studies on the role of urinary macromolecules in urolithiasis: review of methodologies and a proposal for a standard reference crystallization system.
Rodgers AL; Jappie D
Scanning Microsc; 1996; 10(2):535-45; discussion 545-6. PubMed ID: 9813630
[TBL] [Abstract][Full Text] [Related]
54. Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.
Atmani F; Lacour B; Drüeke T; Daudon M
Urol Res; 1993 Jan; 21(1):61-6. PubMed ID: 8456540
[TBL] [Abstract][Full Text] [Related]
55. Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis.
Iida S; Peck AB; Johnson-Tardieu J; Moriyama M; Glenton PA; Byer KJ; Khan SR
J Am Soc Nephrol; 1999 May; 10(5):986-96. PubMed ID: 10232684
[TBL] [Abstract][Full Text] [Related]
56. Reproductive failure in mice lacking inter-alpha-trypsin inhibitor (ITI)--ITI target genes in mouse ovary identified by microarray analysis.
Suzuki M; Kobayashi H; Tanaka Y; Kanayama N; Terao T
J Endocrinol; 2004 Oct; 183(1):29-38. PubMed ID: 15525571
[TBL] [Abstract][Full Text] [Related]
57. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
[TBL] [Abstract][Full Text] [Related]
58. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.
Kavanagh JP; Jones L; Rao PN
Clin Sci (Lond); 2000 Feb; 98(2):151-8. PubMed ID: 10657269
[TBL] [Abstract][Full Text] [Related]
59. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
Kavanagh JP; Laube N
J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
[TBL] [Abstract][Full Text] [Related]
60. Identification of bikunin isolated from human urine inhibits calcium oxalate crystal growth and its localization in the kidneys.
Okuyama M; Yamaguchi S; Yachiku S
Int J Urol; 2003 Oct; 10(10):530-5. PubMed ID: 14516400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
